Evidence map›Paper›PMID 29223978›Full record

ArticleG3 (Bethesda, Md.)2018

PRC2 Is Dispensable

James Ferguson, Mahima Devarajan, Gregg DiNuoscio, Alina Saiakhova, Chia-Feng Liu, Veronique Lefebvre, Peter C Scacheri, Radhika P Atit

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 33% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Cranium growth, patterning and homeostasis.Development (Cambridge, England) · 2022
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

James FergusonDepartment of Biology, Case Western Reserve University, Cleveland, Ohio 44106.
Mahima DevarajanDepartment of Biology, Case Western Reserve University, Cleveland, Ohio 44106.
Gregg DiNuoscioDepartment of Biology, Case Western Reserve University, Cleveland, Ohio 44106.
Alina SaiakhovaDepartment of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio 44106.
Chia-Feng LiuDepartment of Cellular and Molecular Medicine, Cleveland Clinic Lerner Research Institute, Ohio 44195.
Veronique LefebvreDepartment of Cellular and Molecular Medicine, Cleveland Clinic Lerner Research Institute, Ohio 44195.
Peter C ScacheriDepartment of Genetics and Genome Sciences, Case Western Reserve University, Cleveland, Ohio 44106.
Radhika P AtitDepartment of Biology, Case Western Reserve University, Cleveland, Ohio 44106 rpa5@case.edu.
Case Western Reserve University · USCleveland Clinic Lerner College of Medicine · US

Funding

TRAINING PROGRAM IN MUSCULOSKELETAL RESEARCHT32AR007505 · NIAMS · CASE WESTERN RESERVE UNIVERSITY · PI TRIOLO, RONALD J · 1986 to 2023
$6.3M
Sox9-mediated control of chondrogenesisR01AR046249 · NIAMS · UNIVERSITY OF TEXAS MD ANDERSON CAN CTR · PI LEFEBVRE, VERONIQUE M · 1999 to 2015
$4.9M
The role of gene enhancer elements in colon cancerR01CA160356 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI TESAR, PAUL JOSEPH · 2012 to 2023
$3.6M
Genetic mechanisms of craniofacial dermal developmentR01DE018470 · NIDCR · CASE WESTERN RESERVE UNIVERSITY · PI ATIT, RADHIKA P · 2007 to 2018
$3.5M
Roles of SOXC proteins in osteogenic cellsR01AR068308 · NIAMS · CLEVELAND CLINIC LERNER COM-CWRU · PI LEFEBVRE, VERONIQUE M · 2016 to 2020
$2.4M
Role of enhancer elements in regulating prometastatic transcriptional programs in osteosarcomaR01CA193677 · NCI · CASE WESTERN RESERVE UNIVERSITY · PI SCACHERI, PETER CHRISTOPHER · 2016 to 2020
$1.8M
NCI NIH HHS R01 CA160356NCI NIH HHS R01 CA193677NIAMS NIH HHS R01 AR046249NIAMS NIH HHS R01 AR068308NIAMS NIH HHS T32 AR007505NIDCR NIH HHS R01 DE018470
6 · The paper itself

Abstract

A hallmark of craniofacial development is the differentiation of multiple cell lineages in close proximity to one another. The mouse skull bones and overlying dermis are derived from the cranial mesenchyme (CM). Cell fate selection of the embryonic cranial bone and dermis in the CM requires Wnt/β-catenin signaling, and loss of β-catenin leads to an ectopic chondrogenic cell fate switch. The mechanism by which Wnt/β-catenin activity suppresses the cartilage fate is unclear. Upon conditional deletion of β-catenin in the CM, several key determinants of the cartilage differentiation program, including

Indexed as

Animalsbeta CateninCartilageCell DifferentiationChondrogenesisEnhancer of Zeste Homolog 2 ProteinGene Expression ProfilingGene Expression Regulation, DevelopmentalMesodermMice, KnockoutMice, TransgenicPolycomb Repressive Complex 2SkullWnt Signaling Pathwaybeta CateninEnhancer of Zeste Homolog 2 ProteinPolycomb Repressive Complex 2cell fate selectioncranial dermisdevelopmentH3K27me3skull bone

Identifiers

PMID29223978
PMCPMC5919733
OpenAlexW2773133046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.